Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/5/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Gilead Sciences (GILD) PT Lowered to $75 at RBC Capital
February 14, 2024 5:24 AM ESTRBC Capital analyst Brian Abrahams lowered the price target on Gilead Sciences (NASDAQ: GILD) to $75.00 (from $76.00) while maintaining a Sector Perform rating.
The analyst comments "We had the opportunity to sit down with GILD's mgmt to catch up further on their quarter and... More
Gilead Sciences (GILD) to acquire CymaBay Therapeutics (CBAY) in $4.3bn cash deal
February 12, 2024 8:55 AM ESTGilead Sciences (NASDAQ: GILD) announced on Monday that it would acquire CymaBay Therapeutics (NASDAQ: CBAY) for $4.3 billion. The purchase is intended to expand Gilead's portfolio of liver disease treatments.
GILD will pay $32.50 per share in... More
CymaBay Therapeutics (CBAY) to Resume Trading at 9 a.m.
February 12, 2024 8:34 AM ESTCymaBay Therapeutics (NASDAQ: CBAY) to Resume Trading at 9 a.m.
